Select Medical Holdings Corpora (SEM) Stock Analysis
Healthcare · Medical Care Facilities
Sell if holding. Engine safety override at $16.57: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Elevated put/call ratio: 2.40; Below-average business quality.
Select Medical is one of the largest U.S. operators of critical illness recovery hospitals (104 in 28 states), rehabilitation hospitals (38 in 15 states), and outpatient rehabilitation clinics (1,917 in 39 states), generating $5.45B in 2025 revenue. Revenue is earned from... Read more
Sell if holding. Engine safety override at $16.57: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Elevated put/call ratio: 2.40; Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.0/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Select Medical Holdings Corpora
Latest news
- NEWS Select Medical, Carilion Clinic Strike JV To Build, Operate New Inpatient Rehabilitation Hospital In Roanoke, Virginia — benzinga May 21, 2026 positive
- NEWS This Under Armour Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday — benzinga May 13, 2026 neutral
- NEWS Mizuho Downgrades Select Medical Hldgs to Neutral, Lowers Price Target to $16.5 — benzinga May 13, 2026 negative
- NEWS Transcript: Select Medical Hldgs Q1 2026 Earnings Conference Call — benzinga May 1, 2026 neutral
- NEWS Select Medical Hldgs Affirms FY2026 GAAP EPS Guidance of $1.22-$1.32 vs $1.25 Est; Affirms FY2026 Sales Guidance of $5.6 — benzinga Apr 30, 2026 positive
Generated 2026-06-15T18:11:47Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMregulatoryMedicare29%10-K Item 1A: 'Revenues from providing services to patients covered under the Medicare program represented approximately 31%, 29%, and 29% of our revenue for the years ended December 31, 2023, 2024, and 2025, respectively'
Material Events(8-K, last 90d)
- 2026-04-30Item 5.02LOWCompensation Committee approved one-year deferral of scheduled vesting dates for certain equity awards held by Executive Chairman Robert A. Ortenzio and Senior EVP Martin F. Jackson. No new grants, departures, or appointments.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Quality below the gate floor. Component breakdown shows what dragged the score down.static
Negative sentiment — recent news tone and/or analyst downgrades drag the composite below neutral.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $16.57: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Elevated put/call ratio: 2.40; Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $16.47. Score 5.0/10, moderate confidence.
Take-profit target: $16.27 (-1.8% upside). Prior stop was $16.47. Stop-loss: $16.47.
Target reached (-14.7% upside); Quality below floor (3.0 < 4.0); Value-trap signals (3/5): Margin compression (op margin -50.1%), High leverage (D/E 6.1), Material insider selling (7 sells, 0.05% of cap).
Select Medical Holdings Corpora trades at a P/E of 15.5 (forward 12.1). TrendMatrix value score: 7.5/10. Verdict: Sell.
12 analysts cover SEM with a consensus score of 2.5/5. Average price target: $17.
What does Select Medical Holdings Corpora do?Select Medical is one of the largest U.S. operators of critical illness recovery hospitals (104 in 28 states),...
Select Medical is one of the largest U.S. operators of critical illness recovery hospitals (104 in 28 states), rehabilitation hospitals (38 in 15 states), and outpatient rehabilitation clinics (1,917 in 39 states), generating $5.45B in 2025 revenue. Revenue is earned from patient services reimbursed by Medicare (29% of 2025 revenue), commercial insurance, and Medicaid.